Alpine Partners VI »

Cytokinetics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $676k 13k 54.18

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding Cytokinetics

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Investment Management
State Street Corporation
Bank of America Corporation
T. Rowe Price Associates
Armistice Capital
Geode Capital Management
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA
Alliancebernstein
Marshall Wace
Partner Fund Management

View all funds holding Cytokinetics